Latest Cancer News

Novel Agent Granted Fast Track Designation for Refractory Metastatic Colorectal Cancer (10-23-2014)
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to TAS-102, a novel agent currently under investigation for the treatment of refractory metastatic colorectal cancer. According... Continue Reading

FDA Grants Breakthrough Therapy Designation to AP26113 for ALK-Positive NSCLC (10-22-2014)
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to an investigational agent AP26113 for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non–small... Continue Reading

Adding Cediranib to Olaparib Markedly Improves Progression-Free Survival but Increases Toxicity in Recurrent Platinum-Sensitive Ovarian Cancer (10-21-2014)
The addition of the antiangiogenic agent cediranib to the PARP inhibitor olaparib in women with recurrent platinum-sensitive ovarian cancer improves time to cancer progression and survival. The results... Continue Reading

More Cancer News

Locations

La Jolla Location
9850 Genesee Ave
Ste 830
La Jolla, CA 92037
858.552.1410
Fax: 858.552.0929
click here for directions
Encinitas Location
477 N. El Camino Real
Ste D200
Encinitas, CA  92024
760.452.3340
Fax: 760.452.3344
click here for directions
Vista Location
161 Thunder Drive
Ste 106
Vista, CA  92083
760.208.6730
Fax: 760.208.6736
click here for directions
Escondido Location
625 W. Citracado Parkway
Suite 110
Escondido, CA  92025
760.747.8935
Fax: 760.747.7951
click here for directions
4 S Ranch Location
16918 Dove Canyon Road
San Diego, CA 92127
Ste 103
858-649-5100
Fax: 858-649-5099
click here for directions